Efekty biologiczne olejów rybnych. I. Wpływ na lipoproteiny

• Autorzy: Szostak-Wegierek D.

Warianty tytułu

EN

Biological effects of fish oils. I. Influence on lipoproteins

• Języki publikacji: PL

Abstrakty

Jak wynika z przedstawionego przeglądu, oleje rybne wywierają korzystny efekt na umieralność z powodu niedokrwiennej choroby serca. Nie można jednoznacznie stwierdzić, że zależy to od profilu lipoprotein surowicy. Ich wpływ na stężenie aterogennych LDL nie jest jednoznaczny. W wielu przypadkach poziom tej frakcji pod wplywem olejów rybnych ulega podwyższeniu. Wpływ na poziom przeciwmiażdżycowych HDL również nie jest wyraźnie określony. Jedynym pewnym efektem dzialania tych kwasów jest obniżenie poziomu VLDL oraz chylomikronemii, co może mieć znaczenie w leczeniu hiperlipoproteinemii typu IV i V.

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 1991
• Tom: 18
• Numer: 4
• Opis fizyczny: s.309-318,bibliogr.

Twórcy

autor

Szostak-Wegierek D.

• Zakład Szkolenia i Oświaty Zdrowotnej, Instytut Żywności i Żywienia w Warszawie, Warszawa

Bibliografia

• 1. Abbey M., Clifton P., Kestin M., et al.: Effect of fish oil on lipoproteins, lecitin : cholesterol acyltransferase, and lipd transfer protein activity in humans. Arteriosclerosis 1990, 10, 85.
• 2. Bang H.O., Dyerberg J.: Lipid metabolism and ischaemic heart disease in Greenland Eskimos. In: Advanced nutrition research. Ed:H. H. Drapper. New York, Plenum Press, 1980
• 3. Bang H. O., Dyerberg J., Hjerne N:. The composition of food consumed by Greenland Eskimos. Acta Med. Scand., 1976, 200, 69.
• 4. Baudet M.F., Bachet C., Lesserre M., et al.: Modification in the composition and metabolic properties of human low density and high density lipoproteins by different dietary fats. J. Lipid Res., 1984, 25, 456.
• 5. Boberg M., Vessby B., Selinus I.: Effects of dietary supplementation with n-6 and n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients. Acta Med. Scand., 1986, 220, 153.
• 6. Bronsgeest-Schoute H. C., van Gent C. M., Luten J. B., et al.: The effect of various omega 3 fatty acids on the blood lipd composition in healthy human subjects. Amer. J .Clin. Nutr., 1981, 34, 1752.
• 7. Chen I. S., Sheppard A. J., Cassidy M. M., et al.: In vitro clearance of chylomicron triglycerides containing (omega 3) eicosapetaenoate. Atherosclerosis 1987, 65, 193.
• 8. Childs M. T., King I. B., Yamanaka W.K.: Divergent lipoprotein lipid responses to fish oils enriched in eicosapentaenoic acid (EPA) or docosahexaenoic (DHA) (abstr.). FASEB J., 1988, 2, 749.
• 9. Christensen E., Hagve T.A., Christophersen B.O.: Mitochondrial and peroxisomal oxidation of arachidonic and eicosapentaenoic acid studied in isolated liver celles. Biochim. Biophys. Acta 1986, 879, 313.
• 10. Dart A. M., Riemersma R. A., Oliver M. F.: Effect of Maxepa on serum lipids in hypercholesterolaemic subjects. Atherosclerosis 1989, 80, 119.
• 11. Demke D.M., Peters G.R., Linet O.I., et al.: Effects of a fish oil concentrate in patients with hypercholesterolemia. Atherosclerosis 1988, 70, 73.
• 12. Dyerberg J.: Linolenate — derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr. Rev., 1986, 44, 125.
• 13. Dyerberg J., Bang H.O.: Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979, ii, 433.
• 14. Dyerberg J., Bang H.O., Hjørne N.: Fatty acid composition of the plasma lipids in Greenland Eskimos. Amer. J. Clin. Nutr., 1975, 28, 958.
• 15. Failor R. A., Childs M.T., Bierman E.L.: The effects of omega 3 and omega 6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipi- demia. Metabolism 1988, 37, 1021.
• 16. Gianturco S. H., Brown F. B., Gotto A. M., et al.: Receptor — mediated uptake of hypertriglyceridemic VLDL by normal fibroblasts. J. Lipid Res., 1982, 23, 984.
• 17. Goodnight S. H., Harris W. S., Connor W. E., et al.: Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 1982, 2, 87.
• 18. Gordon T., Castelli W.P., Hjortland M.C., et al.: High density lipoprotein as a protective factor against coronary heart disease. Amer. J. Med., 1977, 62, 707.
• 19. Haglund O., Wallin R., Luostarinen R., et al.: Effects of a new fluid fish oil concentrate, ESKIMO-3, on triglycerides, cholesterol, fibrinogen and blood pressure. J. Int. Med., 1990, 227, 347.
• 20. Hagve T., Christopherson B.O.: Evidence for peroxisomal retroconversion of adrecin acid (22:4n6) and docosahexaenoic acid (22:6n3) in isolated liver cells. Biochim. Biophys. Acta 1986, 875, 165.
• 21. Harris W.S., Connor W.E., Alam N., et al.: Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J. Lipid Res., 1988, 29, 1451.
• 22. Harris W.S., Connor W.E., Goodnight S.H.: Dietary fish oils, plasma lipids and platelets in man. Progr. Lipid Res., 1981, 20, 75.
• 23. Harris W. S., Connor W. Ellingworth D. R., et al.: The mechanism of the hypotriglyceridemic effect of dietary omega-3 fatty acids in man (abstract). Clin. Res., 1984, 32, 560A.
• 24. Harris W. S., Connor W. E., Inkeles S. B., et al.: Dietary n-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia. Metabolism 1984, 33, 1016.
• 25. Harris W.S., Connor W.E., McMurray M.P.: The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats. Salmon oil versus vegetable oil. Metabolism 1983, 32, 179.
• 26. Harris W. S., Dujovne C. A., Zucker M., et al.: Effects of a low saturated fat, low cholesterol fish oil (supplement in hypertriglyceridemic patients: a placebo controled trial. Ann. Intern. Med., 1988, 109, 465.
• 27. Harris W. S., Rothrock D. W., Fanning A., et al.: Fish oils in hypertriglyceridemia: a dose — response study. Amer. J. Clin. Nutr., 1990, 51, 399
• 28. Harris W. S., Zucker M. L., Dujovne C. A.: Omega 3 fatty acids in hypertriglyceridemic patients: triglycerides vs methyl esters. Amer. J. Clin. Nutr., 1988, 48, 992.
• 29. Hirai A., Hamazaki T., Terano T., et al.: Eicosapentaenoic acid and platelet function in Japanase. Lancet 1980, ii, 1132.
• 30. Holub B. J., Bakker B. J., Skeaff C. M.: Alterations in molecular species of cholesterol esters formed via plasma lecithin-cholesterol acyltransferase in human subjects consuming fish oil. Atherosclerosis 1987, 66, 11.
• 31. van Houwelingen R., Zevenbergen H., Groot P., et al.: Dietary-fish effects on serum lipids and apolipoproteins, a controlled study. Amer. J. Clin. Nutr., 1990, 51, 393.
• 32. Huff M. W., Telford D. E.: Dietary fish oil increase conversion of very low density lipoprotein apoprotein B to low density lipoprotein. Arteriosclerosis 1989, 9, 58.
• 33. Illingworth D. R., Harris W. S., Connor W. E.: Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans. Arteriosclerosis 1984, 4, 270.
• 34. Kagawa Y., Nishazawa M., Suzuki M., et al.: Eicosapolyenoic acids of serum lipids of Japanene islanders with low incidence of cardiovascular diseases. J. Nutr. Sci. Vitaminol., 1982, 28, 441.
• 35. Klör H. U., Luley G.H.: Omega-3 fatty acid treatment of hyperlipidemia: efficacy and mechanism of action. In: Recent Developments in Lipid and Lipoprotein Research. Lipoprotein Subfractions. Omega-3 fatty acids. Ed: H. U. Klor. Berlin, Springer-Verlag, 1989, 125.
• 36. Knapp H.R., Reilly I.A.G., Allesandrini P., et al.: In vivo indexes of platelet and vascular function during fish oil administration in patients with atherosclerosis. N. Engl. J. Med., 1986, 314, 937.
• 37. Kromann N., Green A.: Epidemiological studies in the Upernavik district, Greenland. Acta med. Scand., 1980, 401.
• 38. Kromhout D., Bosschieter E.B., Coulander C.L.: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. Engl. J. Med., 1985, 312, 1205.
• 39. Lawson L. D., Hughens B. G.: Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem. Bio- phys. Res. Commun., 1988, 152, 328.
• 40. Lorenz R., Spengler U., Fisher S., et al.: Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with codliver oil. Circulation 1983, 67, 504.
• 41. Marsh J. B., Topping D. L., Nestel P. J.: Comparative effects of dietary fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphohydrolase, diacylglycerol acyltransferase and neutral lipase activities. Biochim. Biophys. Acta 1987, 922, 239.
• 42. Nestel P. J.: Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol. Amer. J. Clin. Nutr., 1986, 43, 752.
• 43. Nestel P. J., Connor W. E., Reardon M. R., et al.: Suppression by diets rich in fish oil of very low density lipoprotein production in man. J. Clin. Invest., 1984, 74, 82.
• 44. Norell S., Ahlbom A., Feychting M., et al.: Fish consumption and mortality from coronary heart diseas. Brit. Med. J., 1986, 293, 426.
• 45. Packard C. J., Munro A., Lorimer A. R., et al.: Metabolism of apolipoprotein B in large, triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J. Clin. Invest., 1984, 74, 178.
• 46. Philipson B. E., Rothorck D. W., Connor W. E., et al.: Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N. Engl. J. Med., 1985, 312, 1210.
• 47. Radack K. L., Deck C.C., Huster G.A.: n-3 fatty acid effects on lipids, lipoproteins and apolipoproteins at very low doses: results of a randomized controlled trial in hypertriglyceridemic subjects. Amer. J. Clin. Nutr., 1990, 51, 599.
• 48. Roach P. D., Karribouris A. M., Trimble R. P., et al.: Fish oil down-regulates the low density lipoprotein receptor of ratliver. FEBS Lett., 1987, 222, 159.
• 49. Rustan A. C., Nossen J. O., Christiansen E. N., et al.: Eicosapentaenoic acid reduced hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:l, 2-diacylglycerol acyltransfefrase. J. Lipid Res., 1988, 29, 1417.
• 50. Rustan A. C., Nossen J. O., Osmundsen H., et al.: Eicosapentaenoic acid inhibits cholesterol estrification in cultured parenchymal cells and isolated microsomes from rat liver. J. Biol. Chem., 1988, 263, 8126.
• 51. Sanders T.A.B., Lovat L., Mistry M., et al.: Influence of a mackerel diet on plasma lipoproteins and platelet function. Proc. Nutr. Soc., 1987, 46, 5A.
• 52. Sanders T.A.B., Roshanai F.: The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin. Cci., 1983, 64,
• 53. Sanders T.A.B., Sullivan D.R., Reeve J., et al.: Triglyceride — lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis 1985, 5, 459.
• 54. Sanders T. A. B., Vickers M., Haines A. P.: Effect on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids in healthy young men. Clin. Sci., 1981, 61, 317.
• 55. Saynor R., Verel D.: Effect of a marine oil high in eicosapentaenoic acid on blood lipids and coagulation. IRCS Library Compendium 1980, 8, 378.
• 56. Saynor R., Verel D., Gillott T.: The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis 1984, 50, 2.
• 57. von Schacky C., Fischer S., Weber P.C.: Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J. Clin. Invest., 1985, 76, 1626.
• 58. Schectman G., Kaul S., Kissenbah A. H.: Heterogeneity of low density lipoprotein response to fish-oil supplementation in hypertriglyceridemic subjects. Arteriosclerosis 1989, 9, 345.
• 59. Simons L. A., Hickie J. B., Balasubramaniam S.: On the effects of dietary n-3 fatty acids (Max EPA) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Atherosclerosis 1985, 54, 75.
• 60. Singer P., Jaeger W., Wirth AT., et al.: Lipid and blood pressure — lowering effect of mackerel diet in man. Atherosclerosis 1983, 49, 99.
• 61. Singer P., Witrh M., Berger I., et al.: Influence on serum lipids, lipoproteins and blood pressure of mackerel and herring diet in patients with type IV and V hyperlipoproteinemia. Atherosclerosis 1985, 51, 111.
• 62. Singer P., Wirth M., Voigt S., et al.: Blood pressure — and lipid — lowering effect of mackerel and herring diet in patients with mild essential hypertension. Atherosclerosis 1985, 56, 223.
• 63. Subbaiah P. V., Davidson M. H., Ritter M. C., et al.: Effects of dietary supplementation with marine lipid concentrate on the plasma lipoprotein composition of hypercholesterolemic patients. Atherosclerosis 1989, 79, 157.
• 64. Sullivan D. R., Sanders T. A., Trayner I. M., et al.: Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridemic patients and normal subjects ingesting fish oil. Atherosclerosis 1986, 61, 129.
• 65. Vahouny G.V.: Inhibition of cholesterol absorption by natural products. In: Drugs Affecting Lipid Metabolism. Ed: D. Kritchevksy. New York, Plenum Publishing Corp, 1985, VIII, 265.
• 66. Ventura M.A., Woollett C. A., Spady P. K.: Dietary fish oil stimulation hepatic low density lipoprotein transport in the rat. J. Clin. Invest., 1989, 84, 528.
• 67. Weaver B.J., Holob B.J.: Health effects and metabolism of dietary eicocapentaenoic acid. Prog. Food Nutr. Sci., 1988, 12, 111.
• 68. Weintraub M.S., Zechner R., Brown A., et al.: Dietary polyunsaturated fats of the omega-6 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J. Clin. Invest., 1988, 82, 1884.
• 69. Wilt T.J., Lofgren R.P., Nichol K.L.: Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Ann. Int. Med., 1989, 111, 900.
• 70. Wong S. H., Fisher E. A., Marsh J. B.: Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of vedy low density lipoprotein in Hep G2 cells. Artriosclerosis 1989, 9, 836.
• 71. Wong S.H., Marsh J.B.: Inhibition of apolipoprotein secretion and phosphotidate phosphohydrolase activity by eicosapentaenoic and docohexaenoic acids in the perfused rat liver. Metabolism 1988, 37, 1177.
• 72. Wong S.H., Nestel P. J.: Eicosapentaenoic acid inhibits the secretion of triacylglycerol and apoprotein B and the binding of LDL in Hep G2 cells. Atherosclerosis 1987, 64, 139.
• 73. Wong S.H., Nestel P. J., Trimble R.P.: The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liver. Biochim. Biophys. Acta 1984, 792, 103.
• 74. Wong S.H., Reardon M.F., Nestel P. J.: Reduced triglyceride formation from long chain polyenoic fatty acids in rat hepatocytes. Metabolism 1985, 34, 900.
• 75. Yamazaki R.K., Shen T., Schade C.B.: A diet rich in (n-3) fatty acids increases peroxisomal beta — oxidation activity and lowers plasma triacylglycerols without inhibiting glutathion-dependent detoxication activities in the liver. Biochim. Bophys. Acta 1987, 920, 62.
• 76. Yamori Y., Nara Y., Iritani N., et al.: Comparison of serum phospholipid fatty acids among fishing and farming Japanese populations and American inlanders. J. Nutr. Sci. Vitaminol., 1985, 31, 417.

Uwagi

Rekord w opracowaniu